Haleos Labs Limited (BOM:540679)
India · Delayed Price · Currency is INR 1,586.00
+37.00 (2.39%)
At close: Oct 6, 2026
Haleos Labs Market Cap
Haleos Labs has a market cap or net worth of 4.8 billion as of October 7, 2026. Its market cap has increased by 37.32% in one year.
Market Cap
4.80B
Enterprise Value
6.04B
Revenue
3.24B
Global Rank
n/a
Country Rank
n/a
PE Ratio
30.38
ChartMarket Cap Chart
Since August 17, 2017, Haleos Labs's market cap has increased from 407.69M to 4.80B, an increase of 1,077.46%. That is a compound annual growth rate of 30.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 4.79B | 19.69% |
| Dec 31, 2025 | 4.00B | 12.59% |
| Dec 31, 2024 | 3.56B | 122.05% |
| Dec 29, 2023 | 1.60B | -15.33% |
| Dec 30, 2022 | 1.89B | -14.48% |
| Dec 31, 2021 | 2.21B | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 7.55B |
| ZIM Laboratories | 7.31B |
| Wanbury | 6.95B |
| Albert David | 4.86B |
| Trident Lifeline | 4.49B |
| Medicamen Biotech | 4.28B |
| Jenburkt Pharmaceuticals | 4.08B |
| Astonea Labs | 3.63B |